Duopharma Biotech Berhad (KLSE:DPHARMA)

Duopharma Biotech Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	264.55	270.5	157.64	137.98	158.03
Cash & Short-Term Investments	264.55	270.5	157.64	137.98	158.03
Cash Growth	-2.20%	71.60%	14.25%	-12.69%	30.96%
Accounts Receivable	195.77	135.04	131.31	122.42	112.99
Other Receivables	18.19	26.38	10.84	10.31	22.18
Receivables	213.96	161.42	142.15	132.72	135.17
Inventory	248.55	243.07	235.18	222.19	151.27
Prepaid Expenses	-	2.08	6.52	1.9	0.67
Other Current Assets	-	-	-	-	14.56
Total Current Assets	727.05	677.07	541.49	494.8	459.69
Property, Plant & Equipment	566.29	582.37	579.92	542.53	441.79
Long-Term Investments	22.67	36.91	42.15	73.54	112.25
Other Intangible Assets	44.98	7.65	3.84	4.95	4.66
Long-Term Deferred Tax Assets	14.97	8.95	13.33	12.7	8.54
Long-Term Deferred Charges	-	31.15	40.14	34.58	30.41
Other Long-Term Assets	1.05	1.05	1.05	1.05	1.1
Total Assets	1,377	1,345	1,222	1,164	1,058
Accounts Payable	128.7	44.53	51.93	31.32	28.15
Accrued Expenses	-	33.79	40.46	61.2	45.62
Short-Term Debt	-	50.59	101.8	87.85	36.11
Current Portion of Long-Term Debt	48	14.95	32.34	15.08	12.68
Current Portion of Leases	-	0.92	0.94	0.64	0.6
Current Income Taxes Payable	0.74	0.37	1.17	6.06	0.74
Other Current Liabilities	-	21.58	35.95	28.17	26.41
Total Current Liabilities	177.43	166.73	264.59	230.31	150.32
Long-Term Debt	464.52	480.9	294.6	297.8	253.28
Long-Term Leases	2.83	1.48	1.92	2.48	0.66
Long-Term Deferred Tax Liabilities	23.06	8.91	5.58	9.54	10.35
Total Liabilities	667.85	658.01	566.7	540.13	414.61
Common Stock	432.47	432.47	419.37	405.86	404.92
Retained Earnings	354.78	319.07	288.37	239.97	220.18
Comprehensive Income & Other	-78.09	-64.41	-52.52	-21.82	18.72
Shareholders' Equity	709.15	687.12	655.22	624	643.82
Total Liabilities & Equity	1,377	1,345	1,222	1,164	1,058
Total Debt	515.35	548.85	431.6	403.84	303.33
Net Cash (Debt)	-250.81	-278.35	-273.97	-265.86	-145.31
Net Cash Per Share	-0.26	-0.29	-0.29	-0.29	-0.16
Filing Date Shares Outstanding	961.94	961.94	952.24	941.77	941.37
Total Common Shares Outstanding	961.94	961.94	952.24	941.77	941.37
Working Capital	549.62	510.34	276.9	264.49	309.37
Book Value Per Share	0.74	0.71	0.69	0.66	0.68
Tangible Book Value	664.18	679.47	651.38	619.06	639.16
Tangible Book Value Per Share	0.69	0.71	0.68	0.66	0.68
Land	-	65.68	69.88	69.88	69.88
Buildings	-	265.86	125.23	124.51	119.57
Machinery	-	435.18	368.47	308.94	291.64
Construction In Progress	-	8.48	172.65	162.63	65.81

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.